Description

• Located in Rochester, NY, Vaccinex is a privately held, clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies, therapeutic vaccines and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases. We conduct discovery research in-house and in collaboration with world-class academic institutions and biotechnology companies, and have an experienced in-house drug development management team to advance our pre-clinical and clinical stage biopharmaceutical development programs. Our development team is led by seasoned industry veterans with both operational and executive level biopharmaceutical industry experience in therapeutic biologics research, manufacturing, quality assurance, quality control, toxicology, pharmacology, drug regulatory affairs, and clinical affairs. We are committed to innovation in the way we approach drug discovery and development. We are committed to identifying and advancing therapeutics that work in novel ways to address unmet medical needs. We are committed to successfully meeting the challenge of treating patients with safe and effective medicines. We are committed to the patients who may use our drugs, and to our shareholders, our employees, and our community all stakeholders in our success.
• 

  Headquarters:1895 Mt Hope Avenue , Rochester, New York, United States

  More
• 

  Phone Number: +1 585-271-2700

• 

  Website: http://www.vaccinex.com/

• 

  Employees:32

• 

  Revenue:$1 - 10M

• 

  Legal Name:Vaccinex, Inc

• Vaccinex, Inc's Social Media

  
• Is this data correct?

• |  NAICS Code: 0  |

  Show More